ShareValue scores for 000739.SHE: Valuation 52, Quality 60, Growth 43, Health 65.

000739.SHE
SZSE

Apeloa Pharmaceutical Co Ltd

CN¥19.51(-4.41%)

Updated

Loading chart...
Sentiment

Pulse

Rating

Moderate

Trap Risk

P/E to median

Not enough data
Valuation
52
Fair Value

vs Shenzhen-listed Healthcare stocks

Price vs Value
Quality
60
Moderate
Business Strength
Growth
43
Moderate
Revenue & Earnings
Health
65
Moderate
Financial Stability
Price trend
48
Neutral
Separate from the four scores

Company Details

About

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects; pharmaceutical business includes anti-infective, cardiovascular, psychotropic, hepatobiliary and anti-tumor categories. The company also provides technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification; and controlled-release formulation development, taste masking technology, and particle flow simulation. In addition, it exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China. Address: No.399 Jiangnan Road, Dongyang, China, 322118

Score Analysis

AI Investment Thesis

Data as of:Nov 13, 2026

By using ShareValue.ai you agree to our Terms and Privacy Policy. Educational platform, not investment advice.